Moreover, 20% of EBV-positive DLBCLs have SVs of PD-L1 and PD-L2 with resulting truncation of the 3′-untranslated regions (3′UTRs) [93] and associated with increased expression of PD-L1 protein on the surface of tumor cells [37]. The gene discussed is PDCD1LG2; the disease is neoplasm.